Project Description
Schwarzer Cardiotek entwickelt, produziert und vertreibt hämodynamische und elektrophysiologische Messsysteme und Datenmanagementlösungen für die interventionelle Kardiologie.
Mit mehr als 1.000 hämodynamischen Installationen und über 900 installierten EP-Systemen ist das Unternehmen nach 60 erfolgreichen Jahren im Markt für starke Partnerschaften im Bereich der Kardiologie bekannt.
2017
EP-Tracer 2.2 software release
2016
FDA approval for the EP-Tracer 2
2015
A new software version of the EP-Tracer 2, which, among other things, makes possible the integration of cryoablators. The EP-Tracer is marketed in Europe, Central and South America, the USA, the Asia-Pacific area, and in the Near and Middle East.
2014
Product partnership between Schwarzer GmbH and the Dutch company CardioTek, based in Maastricht, leads to the legal merger of the two companies under the new name of Schwarzer Cardiotek GmbH
2010
Schwarzer GmbH moves the rest of its offices and operations from Munich to the Zukunftspark in Heilbronn
2008
Relocation of company headquarters; Schwarzer GmbH is managed from now on under the umbrella of the Zukunftsfonds in Heilbronn
2002
CardioTek introduces the first laptop-based EP system worldwide – the EP-Tracer Portable, a mobile version of the EP-Tracer.
2001
Founding of the CardioTek company as a spin-off from the University of Maastricht
1988
Development of the first digitally functioning EEG device in the world that features signal transmission utilizing fiber optics
1969
Sale of Schwarzer GmbH to the American Optical company, continued existence of a company called Schwarzer G.m.b.H.
1968
The first industrially produced device for multichannel EEG analysis
1951
Founding of the Fritz Schwarzer GmbH in Munich